vimarsana.com
Home
Live Updates
Imfinzi, Lynparza Combination Improves PFS in Patients With
Imfinzi, Lynparza Combination Improves PFS in Patients With
Imfinzi, Lynparza Combination Improves PFS in Patients With Ovarian Cancer in Phase 3 Trial
Individuals treated with the drugs from AstraZeneca demonstrate clinically meaningful and statistically significant improvement.
Related Keywords
Germany ,
Susan Galbraith ,
Kliniken Essen Mitte ,
Philipp Harter ,
Astrazeneca ,